The abnormal regulation of the Ke 6 gene has been linked to the development of recessive polycystic kidney disease in the mouse. In this report, we have shown that Ke 6 is a 17␤-hydroxysteroid dehydrogenase and can regulate the concentration of biologically active estrogens and androgens. The Ke 6 enzyme is preferentially an oxidative enzyme and inactivates estradiol, testosterone, and dihydrotestosterone. However, the enzyme has some reductive activity and can synthesize estradiol from estrone. We find that the Ke 6 gene is expressed within the ovaries and testes. The presence of Ke 6 protein within the cumulus cells surrounding the oocyte places it in a strategic location to control the level of steroids to which the egg is exposed. Previously, it had been shown that glucocorticoids can induce renal cysts in the neonatal rodent, only when given at a narrow time window of postnatal kidney development. We propose that the reduction in the level of Ke 6 enzyme, which occurs in the cpk, jck, and pcy mice, may lead to abnormal elevations in local level of sex steroids, which either directly or indirectly via abnormal glucocorticoid metabolism result in recessive renal cystic disease, a developmental disorder of the kidney.
1 that have been examined to date: cpk, jck (1, 3) and pcy mice (2) . The inhibition of the Ke 6 gene expression using antisense deoxyoligonucleotides in embryonic kidneys in organ cultures gives rise to numerous cysts against a background of normal nephrogenesis (5, 6) . Importantly, the human Ke 6 gene is located on chromosome 6p21 (7) where the human autosomal recessive PKD mutation has been mapped (8) and therefore there is a possibility that the Ke 6 gene is the primary mutation in autosomal recessive PKD. The structure of the mouse Ke 6 gene (2), cDNA (1) , and protein (4) has been extensively characterized in our laboratory.
Our earlier data base searches with the Ke 6 sequence showed that it belongs to the short-chain dehydrogenase/reductase family (1) . At that time, Ke 6 was most similar to bacterial oxidoreductases with no close similarity to any mammalian oxidoreductase in the data base, leaving the exact function of Ke 6 unknown. Recently, we searched the data base again with Ke 6 and found it is similar to 17␤HSD4 (9) . This prompted us to examine Ke 6 for 17␤HSD activity with various androgen and estrogen substrates.
As reported here, we find that Ke 6 protein is an NAD-dependent 17␤HSD, making it the seventh member of this class of enzyme. It efficiently catalyzes the oxidation of estradiol, testosterone, and dihydrotestosterone and also the reduction of estrone to form biologically active estradiol. The identification of the substrate of Ke 6 allows us to postulate that regulated sex steroid metabolism plays a crucial role in the development of the mammalian kidney, and aberrations in this regulation leads to developmental problems. We propose that the developing kidney is affected by abnormal estrogen/androgen metabolism or by abnormal glucocorticoid metabolism, which could occur as a consequence of elevated sex steroid levels. Estrogen levels have been implicated in the inhibition of 11␤HSD enzyme in a study by Low et al. (10) , where it was determined that gonadectomy of the normal female mouse stimulated the expression of the 11␤HSD1 gene and estradiol replacement inhibited its activity. Elevated levels of estrogens and androgens in the cpk/cpk kidney could result in a defect in glucocorticoid metabolism by the inhibition of 11␤HSD1.
The involvement of a steroid dehydrogenase in renal cyst formation is particularly intriguing since previously several laboratories had demonstrated that the rodent kidney is extremely vulnerable to cyst formation in response to steroid administration at a critical time in development (11) (12) (13) (14) (15) (16) (17) . Moreover, the cystogenic potential of glucocorticoids has been directly demonstrated in metanephric kidneys in organ culture by us (5) and others (18) . Recessive PKD in humans and mice is primarily a developmental disorder and is clinically, phenotypically, and genetically distinct from the autosomal dominant form of PKD, which manifests in adults (19) . Autosomal recessive PKD in humans occurs in neonates or in early childhood and is usually fatal due to the severity of kidney maldevelopment (19) .
In this study we have identified the substrates of Ke 6 and have characterized its kinetic properties and phylogeny. We have used Northern and Western analyses to show that Ke 6 is expressed in the ovary and testis, which are targets for estrogen and androgens, as is the kidney. We have also localized the expression of Ke 6 within the rat ovary. These findings support a function of Ke 6 as a 17␤HSD, a regulator of sex steroid concentrations in these tissues.
MATERIALS AND METHODS
Phylogenetic Analysis-The Feng-Dolittle algorithm (20) was used to construct the phylogenetic tree of mouse Ke 6 and its homologs. The method of Fitch and Margoliash (21) was then used to obtain the branch order for the sequences. Branch lengths are calculated by a linear regression analysis of the best fit of the pairwise distances and the branching order. The lengths of the branches are proportional to the relative distance between the sequences.
Recombinant GST-Ke 6 Fusion Protein-The full-length mouse Ke 6a cDNA (13.3.1) (1) was cloned into the NotI-SalI sites of pGEX vector, and the reading frame of Ke 6 protein was checked by sequencing of the vector-Ke 6 juncture. Transformed bacteria were grown in LB containing 50 g/ml ampicillin at 37°C for 5-6 h. 0.1 mM isopropyl-1-thio-␤-D-galactopyraonoside was added for induction of protein synthesis when the cell density reached a A 600 ϭ 0.8 -1.0. The cells were incubated for 2-3 h at 25-30°C. Cells were harvested, ultrasonicated on ice, and incubated with 0.1 mg/ml lysozyme, 1% Triton X-100 at 4°C for 15 min. After centrifugation, the supernatant was incubated with preswollen 50% glutathione-bonded Sepharose (Amersham Pharmacia Biotech).
After binding for about 1 h at room temperature, the Sepharose was washed with PBS and the GST-Ke 6 protein was eluted with 10 mM reduced glutathione at room temperature. The purity and molecular weight of uncleaved and thrombin-cleaved protein was checked by SDS-PAGE and Western analysis.
Ke 6 Antibody-The polyclonal Ke 6 antibody used in this study was generated by the injection of two rabbits (R3664 and R3691) with a 13-residue Ke 6 peptide from amino acids 54 -65 synthesized by a commercial facility. The peptide was conjugated to diphtheria toxin, and immunization was carried out over a 5-month period, with intervals of 3 weeks between boosts. The antiserum from R3664 was used for Western analysis and the antiserum from R3691 was used for immunohistochemistry. The generation and characterization of these antibodies have been described previously (4) .
SDS-PAGE and Western Blot Analysis-2 g of affinity-purified Ke 6-GST protein and thrombin cleaved Ke 6-GST protein were separated on a 80 ϫ 60 ϫ 1-mm 12% polyacrylamide gel with a 4% stacking gel according to the protocol described by Laemmli (22) . The electrophoresis was carried out in 25 mM Tris, pH 8.3, 200 mM glycine, 0.1% SDS at 80 V. The gel was stained with Coomassie Blue stain, destained, and photographed. For Western blot analysis, 25 ng of protein were loaded onto 12% SDS-PAGE gels and run in conditions described above. After electrophoresis, the gel was electrotransferred at 25 V in transfer buffer (200 mM glycine, 250 mM Tris base, and 20% methanol) onto Immobilon-P membranes, and Western analysis was performed as described previously (4) . The primary antibody (1:250) was applied to the membrane in 1% bovine serum albumin, PBS, 0.1% Tween 20 for 1 h and then washed in PBS and incubated with the secondary antibody (peroxidase-conjugated goat antibody to rabbit IgG) in PBS, 0.1% Tween 20, washed in PBS, and developed using the ECL kit from Amersham Pharmacia Biotech. The membrane was stripped in 100 mM ␤-mercaptoethanol, 63.5 mM Tris, pH 6.7, 2% SDS at 70°C for 30 min. After washing the membrane was antibody-treated the same way as described above. For peptide blocking experiment, the same Western membrane was stripped and treated with the same concentration of Ke 6 antisera (1:250) preblocked overnight with 2 mg/ml peptide in PBS at 4°C.
Enzyme Assays-3 g of Ke 6 protein was used in steroid assays. The GST protein was used as a negative control and showed no steroid metabolic activity. The reaction was carried out with 14 C-labeled steroids in 50 mM Hepes buffer and 1 mM NAD/NADP for oxidation reactions or potassium phosphate buffer and 1 mM NADH/NADPH for reduction reactions. The reaction mixture contained 20% glycerol, 1 mM MgCl 2 , 1 mM EDTA, and 1 mM dithiothreitol as described previously (23) . The ethanol concentration was constant in all reactions with different amounts of steroid. For concentration dependence curves, steroids were added to the reaction mixture at the 10 nM to 5 M range. The reaction time and protein concentrations were within the linear period of the reaction, and all experiments were repeated at least five times. The steroids were extracted with an equal volume of methylene dichloride, dried in a Speed Vac, and applied to TLC on silica gel plates (Whatman) in 30 l of methylene dichloride and then separated in benzene-acetone (4:1) solvent system. The plates were exposed to Kodak BioMax MS autoradiography films for all 14 C-labeled compounds. For the two 3 H-labeled substrates (retinol and androstenediol), the plates were exposed to the film in Transcreen filters. The signals were quantitated using the Collage software. The conversion of a specific substrate to its 17␤HSD product was determined by running radiolabeled standards of both the substrate and product on the TLC and identifying the conversion of steroids by their migration with the standards. To determine the conversion of dihydrotestosterone, unlabeled androstanedione was run as a standard on the TLC, and its migration was detected by UV light. Steady state reaction velocities were obtained from plots of steroid production and analyzed using the GraphPad software (GraphPad, San Diego, CA).
RNA Preparation and Northern Analysis-Poly(A)
ϩ RNA was extracted from kidney, spleen, testis, and ovaries of 6-week-old C57Bl/J6 mice as described previously (1) (2) (3) (4) . RNA was separated on a 1% agarose-formaldehyde gel followed by blotting onto nylon membrane (Magnagraph, Micron Separations). Hybridization and washing of the blots was carried out as described previously (1) (2) (3) (4) .
Immunochemistry-The ovaries from 23-day-old Sprague-Dawley rats (Taconic Technical Service, Germantown, NY) were infiltered with O.C.T. compound (Miles, Inc., Elkhart, IN) and frozen in liquid nitrogen. Ten-micron sections of the ovaries were fixed in acetone at 20°C. After blocking and permeabilization in 1% horse serum in 0.2% Triton X-100, the sections were incubated with rabbit anti-mouse antibody to Ke 6 protein at 1:100 dilution in PBS overnight at 4°C. The immunostaining was done according to the procedure described previously (24) . After thorough washing in PBS, the sections were incubated with goat anti-rabbit IgG conjugated to fluorescein isothiocynate for 1 h. Ovary (1) and uncleaved Ke 6-GST protein (2) were run on a SDS-PAGE, 12% gel, as described above, and the proteins were electroblotted onto an Immobilon-P membrane. The transfer was carried out for 12-14 h at 25 V in transfer buffer (200 mM glycine, 250 mM Tris base, and 20% methanol). The application of the antibody and membrane washing conditions are described under "Materials and Methods." The migration of molecular mass standards are indicated on the left side of the Western blot. The 61-kDa fusion protein is cleaved to the expected 34-kDa size for the Ke 6 protein.
sections were examined for the localization of Ke 6 protein on a Zeiss LSM 410 confocal microscope, and images were recorded with Adobe Photoshop software.
RESULTS

Phylogenetic Analysis Shows Ke 6 Is Close to Mammalian
17␤HSD4 -When Ke 6 was first cloned and sequenced, its homology with short-chain dehydrogenase/reductase was noted (1) . The proteins closest to Ke 6 were bacterial enzymes; there was no striking sequence similarity to a mammalian enzyme. However, our recent data base search uncovered an intriguing similarity between Ke 6 and human 17␤HSD4, which are 35% identical. The sequence similarity extends over the entire length of the protein. The level of homology among mammalian steroid dehydrogenases is not particularly high, and there is only about 22-25% identity among other members of the 17␤HSD family and between 11␤HSD1 and 2 (25) . Therefore, a 35% identity with 17␤HSD4 was considered significant since proteins with this degree of sequence similarity may have similar function (26, 27) .
To depict the relationship of Ke 6 to 17␤HSD4 and other 17␤HSD enzymes, we constructed the phylogenetic tree shown in Fig. 1 . In agreement with our earlier analysis (1), Ke 6 is closest to Escherichia coli acyl carrier protein reductase and 7␣-hydroxysteroid dehydrogenase; the closest mammalian protein is 17␤HSD4. The branch lengths on the tree are proportional to the relative distance between proteins. Thus, Ke 6 is 124 units from 17␤HSD4 and 116.9 units from 7␣HSD, which metabolizes bile acids. Ke 6 is 149.5 units from 17␤HSD2 and most distant from 17␤HSD1.
The similar distance of Ke 6 from mammalian 17␤HSD4 and bacterial 7␣HSD, the activity of androgens and estrogens in the kidney, and the evidence that steroid hormones are involved in cyst formation (11) (12) (13) (14) (15) (16) (17) suggested to us that Ke 6 could metabolize a steroid. This prompted us to examine Ke 6 for 17␤HSD activity as described next.
Identification of the Androgenic/Estrogenic Ke 6 Substrates and Determination of the Kinetic Properties of Ke 6 Protein-
The full-length mouse Ke 6 cDNA was cloned into pGEX expression vector to produce a glutathione transferase-Ke 6 fusion protein. The purity of the recombinant protein produced in bacteria was determined by SDS-PAGE ( Fig. 2A) . The 61-kDa GST-Ke 6 fusion protein is cleaved by thrombin to 34 kDa which is the native molecular mass for Ke 6 protein. We determined that the Ke 6-GST fusion protein had the correct reading frame by sequencing of the vector-cDNA junction and also by Western blot analysis (Fig. 2B) . Antisera raised against a 14-amino acid synthetic Ke 6 peptide recognizes the Ke 6-GST fusion protein, indicating that the correct reading frame of the Ke 6 protein is maintained in the recombinantly produced protein. For the initial identification of the substrates of Ke 6, we used radiolabeled androstenediol, estradiol, testosterone, dihydrotestosterone in oxidation reactions, and radiolabeled estrone, androstenedione, and dehydroepiandrosterone in reduction reactions with the appropriate cofactors. We found that Ke 6 uses NAD/NADH as the cofactor. Ke 6 can oxidize estradiol, testosterone, and dihydrotestosterone (Fig. 3) but not androstenediol (not shown). In the reductive mode, Ke 6 can convert estrone into estradiol, but cannot convert androstenedione (Fig. 3) or DHEA (not shown). The reduction of androstanedione by the Ke 6 enzyme has not yet been examined.
In Fig. 4 , the Michaelis-Menten characteristics of the Ke 6 enzyme for all four of its substrates is shown. The enzyme has the highest oxidative activity over estradiol physiological function. Testosterone and dihydrotestosterone are also inactivated at a lower efficiency. Ke 6 has weaker reductive function and can convert estrone into estradiol. Physiologically, the reductive mode of the Ke 6 enzyme may only be functional in the ovary (discussed below) and not in the nongonadal tissues. The direction of the oxidative and reductive reactions catalyzed by the Ke 6 enzyme may be regulated by phosphorylation or glycosylation within particular tissues or driven by a specific physiologic condition. There are several potential casein, serine, and threonine kinase and glycosylation sites within the protein (1).
Ke 6 Does Not Have Any 7␣HSD, 11␤HSD, or Retinol Dehydrogenase Activity-Because of the close homology of Ke 6 with bacterial 7␣HSD, we examined the Ke 6 protein for 7␣HSD activity using a spectrophotometric assay which detects changes in A 340 nm readings during the oxidation/reduction of the cofactors. Cholic acid and chenodeoxycholic acid were tested as substrates for 7␣HSD oxidation in the presence of NADP or NAD. There was no change in the spectophotometric readings in the Ke 6 reactions or the GST protein (negative control) reactions with cholic acid or chenodeoxycholic acid as substrates with either cofactors. In addition, we also examined if cholic acid would be able to inhibit the oxidation of estradiol.
Steroid conversion assays with 100 nM of radiolabeled estradiol as the substrate and varying amount of cholic acid (10 nM, 100 nM, 200 nM, 1 M, and 10 M) as the inhibitor did not show any difference in estradiol oxidation. Therefore, cholic acid is not a substrate for the Ke 6 enzyme as it cannot act as an inhibitor at even very high concentrations.
11␤HSD activity of the Ke 6 protein was investigated by two methods. The Ke 6 cDNA was cloned into a mammalian expression vector and stably transfected into Chinese hamster ovary cells. Stably transfected Chinese hamster ovary cells carrying the 11␤HSD1 cDNA in the same expression vector pcDNA3 and also the empty vector were used as positive and negative controls. The expression of the Ke 6 and 11␤HSD1 mRNAs were detected in the stable cell lines by Northern blot analysis. These cell homogenates were used for the determination of 11␤HSD activity by the oxidation of corticosterone and by the reduction of dehydrocorticosterone. We have also used GST-Ke 6 fusion protein to determine if it has 11␤HSD activity by monitoring the conversion of radiolabeled cortisol and corticosterone to their oxized products by TLC. By both of these direct methods, the answer has been negative.
The recent finding that retinol dehydrogenase-1 can also oxidize sex steroids (28) led us to test whether retinol is a
FIG. 5. Lineweaver-Burk plots of the conversion of (A), estradiol (E2), (B), testosterone (T), (C), dihydrotestosterone (DHT), and estrone (E1) (D) by the Ke 6 enzyme.
The results of four to six independent experiments were used for linear regression calculation (R Ͼ 0.9). Experiments were performed using affinity-purified Ke 6 recombinant protein as described under "Materials and Methods." Raw data were analyzed with the GraphPad program to calculate K m and V max values.
substrate for the Ke 6 enzyme.
3 H-Labeled retinol was used as a substrate in reactions with recombinant Ke 6 protein or GST protein and either cofactors, NAD or NADP. There was no oxidation of retinol, which confirmed that Ke 6 does not have any retinol dehydrogenase activity.
Expression of the Ke 6 Gene in the Gonads-We examined the level of expression of the Ke 6 gene within the ovary and testis because of the enzymatic activity of Ke 6 on sex steroids. Northern blot analyses were performed to compare the level of expression of the Ke 6 mRNA within the kidney, spleen, ovary, and testis (Fig. 6A) . The level of the Ke 6 mRNA in the gonads is slightly less than in the kidney. Interestingly, in the ovary and the testis the length of the Ke 6 mRNA appears to be slightly longer than that in the kidney, which could be due to differences in poly(A) tail lengths. The gonadal Ke 6 mRNA does not represent Ke 6b, the spleen-specific transcript, which is about 1.2 kilobase pairs and distinctly larger than the Ke 6a mRNA. The cloning and sequencing of the Ke 6b transcript has determined the presence of an unspliced intron which is responsible for the difference in length between the Ke 6a and Ke 6b mRNAs (2) . The Ke 6 gene has been fully sequenced, and there are no unknown splice acceptor-donor sites (2) . Therefore, it is unlikely that the slightly longer transcript seen in the gonads is due to an alternately spliced transcript of the Ke 6 gene.
Protein from the kidney, ovary, spleen, and testis were run on a 10% SDS-PAGE gel and then electroblotted for Western analysis (Fig. 6B) of the endogenous Ke 6 protein. The size of the Ke 6 protein in the ovary and testis is similar to the Ke 6 protein size in the kidney. However, the molecular size of the Ke 6 protein in the spleen is slightly larger than the Ke 6 protein in the kidney and gonads. This is perhaps because in spleen the alternatively spliced Ke 6b transcript gives rise to a protein which is longer than the Ke 6a protein at the carboxyl terminus by 15 amino acids as a result of an alternative splicing event (2) . The molecular mass of the carboxyl-terminal peptide present in the Ke 6b protein is 2.1 kDa and could therefore account for the small mobility difference between the spleen and kidney forms of the Ke 6 protein. The level of Ke 6 protein is lower in the testis than that in the ovary. It is possible that the Ke 6 protein level in the testis is controlled by translational or post-translational mechanisms reflecting the requirement of the testis for this oxidative 17␤HSD. Because of the strong estradiol inactivating ability of Ke 6 and its high affinity for binding estradiol, it may be necessary to suppress the protein level of Ke 6 in the testis to preserve the low level of intratesticular estradiol synthesis which is needed in the male. The amount of Ke 6 protein is highest in the kidney, which corroborates with the level of Ke 6 mRNA.
Localization of Ke 6 Protein in the Ovary-Cryostat sections of rat ovaries were treated with polyclonal Ke 6 antisera. Intense Ke 6-specific immunostaining was visible within the cumulus cells immediately surrounding the oocyte (Fig. 7) . The mural granulosa cells and theca cells were nonimmunoreactive. The 17␤HSD activity of Ke 6 suggests its role in regulating estrogens and androgens levels in the ovary, and consequently its role in follicle maturation and differentiation. It is very intriguing that Ke 6 is present in a key location within the ovary, the cumulus cells, which remain attached to the oocyte even when the oocyte is expelled from the follicle in ovulation. The strategic location of Ke 6 indicates that it plays a very important role in steroid regulation, which either protects the egg from its microenvironment or provides the egg with a critical steroid for its ongoing differentiation. Moreover, the Ke 6 protein could serve as a useful marker of cumulus cells because it is the only known marker of this cell type. The Ke 6 protein is also present in endothelial cells of the blood vessels within the ovary (Fig. 7C) . Previously, Ke 6 staining was also seen in the glomerulus in the kidney (4). The presence of Ke 6 within endothelial cells, in general, may serve to regulate the steroid levels of the blood that enters the target tissues, and in this regard, Ke 6 could control the amount of biologically potent steroid that enters all tissues. However, if Ke 6 protein is found only in blood vessels of particular organs, for example, the kidney and ovary, then its 17␤HSD activity could play an important role in controlling the hormone level in blood that infiltrates that organ and reflect the local needs of that tissue.
DISCUSSION
The enzyme 17␤HSD catalyzes a key reaction in the biosynthesis and metabolism of sex steroids in both gonadal and nongonadal tissues (29) . Oxidoreduction at carbon 17 of estrogens and androgens, carried out by 17␤HSDs, modulates the levels of biologically active estrogens and androgens within tissues. The levels of estrogens and androgens in turn control a variety of important physiological functions, such as growth, reproduction, and differentiation. To date, six isozymes of the 17␤HSD family have been identified and characterized, and in addition, it has been determined that retinol dehydrogenase also possesses 17␤HSD activity (29) . The enzymes belong to the short-chain alcohol dehydrogenase family and use nicotinamide adenine dinucleotide or its phosphate as cofactors. The seven 17␤HSDs (including retinol dehydrogenase) have different substrate and cofactor specificities, tissue distributions, and subcellular localizations, which suggests each of these enzymes has a distinct physiological role in endocrine (glandular) and intracrine (local) metabolism of sex steroids (30). ϩ RNA from normal mouse kidney (K) and testis (T) were run on 1% agarose-formaldehyde gels. Blotting, hybridization, and washing were done as described under "Materials and Methods." In B, 40 g of protein from normal (ϩ/ϩ) and cpk/cpk mouse kidney (K), 40 g of protein from normal mouse testis (T) and ovary (O), Ke 6a cDNA transfected Chinese hamster ovary cells (C), and 80 g of protein from normal mouse spleen (S) were run on a 10% SDS-PAGE gel. The immunoblotting using Ke 6 antisera at 1:250 dilution was done as described under "Materials and Methods." In the bottom panel, the Western membrane was stripped and then treated with the same concentration of Ke 6 antibody preblocked with a 13-amino acid peptide to which the Ke 6 antisera were raised. The details of the stripping and antibody blocking protocol are described under "Matrials and Methods." The arrowhead indicates the absence of Ke 6 protein signal.
In Table I , we have compared Ke 6 to other 17␤HSDs (28, 29, (31) (32) (33) (34) (35) . Ke 6 is similar to 17␤HSD2, 17␤HSD4, and 17␤HSD6 in preference for NAD ϩ as a cofactor and for oxidative activity. However, Ke 6 also has reductive activity for estrone, suggesting a broader role in regulating the sex steroid concentration. These enzymatic differences, which distinguish Ke 6 from the other 17␤HSDs, are in agreement with the phylogenetic analysis ( Fig. 1) , which shows that Ke 6 is on a branch that is clearly distinct form the other 17␤HSDs, and that the closest enzymes to Ke 6 are an E. coli reductase and two steroid dehydrogenases: 7␣HSD and 17␤HSD4, which oxidize their substrate.
An important function of the ovary is the synthesis and secretion of 17␤-estradiol, and this involves two cell populations (36) . DHEA, produced by the adrenals, is released into the circulation and taken up by the well vascularized theca cells where it is converted into androstenediol by 3␤HSD (37). Androstenedione is then aromatized into estrone by P450 aromatase in the granulosa cells (37) . Estrone can then be converted into the biologically active estradiol by the reductive activity of 17␤HSDs. Alternatively, androstenedione may be converted to testosterone by an androgenic 17␤HSD to testosterone, which is then aromatized to estradiol (34) . The localization of Ke 6 protein within the cumulus cells confirms the presence of more than one 17␤HSD within the ovary. 17␤HSD1, an NADPH-dependent enzyme that is expressed at high levels in the ovary, is found in the granulosa cells of primary and antral follicles (38) . Type 2, 3, 4, and 6 17␤HSDs are not present in the ovary (39) . The physical separation of the two 17␤HSDs, Ke 6, and the 17␤HSD1 within the ovary, achieved by the cellular organization of granulosa cells and cumulus cells within the follicle, is interesting. The location of 17␤HSD1 within the granulosa cells and Ke 6 within the cumulus cells may allow the ovary to achieve a fine tuned balance of the optimal sex steroid levels. 17␤HSD1 has strong reductive activity and synthesizes estradiol (40) . Whereas Ke 6 has both oxidative and reductive activities, inactivating and synthesizing estradiol. The smaller Michaelis constant of Ke 6 and its greater activity with estradiol over estrone suggest that it is primarily an oxidative enzyme that can switch to a reductive mode determined in the appropriate physiologic milieu. Because the Ke 6 enzyme can inactivate androgenic steroids, which 17␤HSD1 cannot do, the strategic location of Ke 6 within the cumulus cells could have a critical role in protecting the egg from exposure to androgen, which is known to be produced by the ovary. It is also possible that after ovulation, when the oocyte is within the oviduct, it is supplied estradiol that is synthesized within the cumulus cells by the reductive activity of the Ke 6 enzyme.
The kidney is also a highly steroid-sensitive organ equipped with several steroid dehydrogenases, which inactivate glucocorticoids and sex steroids. The particular location of specific 17␤HSDs and 11␤HSD enzymes along the nephrons may serve specific needs. Besides Ke 6, the kidney expresses 17␤HSD2, 17␤HSD4, and 17␤HSD6, which are also oxidative enzymes and use the same cofactor as the Ke 6 enzyme. The Ke 6 protein is located within the S3 segment of the proximal tubules and within the intercalated cells of the collecting ducts (4) . 11␤HSD1 is present in the proximal tubules (41); 11␤HSD2 is present in the collecting ducts (42) . The location of 17␤HSD2, 17␤HSD4, and 17␤HSD6 within the kidney has not been determined to our knowledge. The presence of four 17␤HSDs and two 11␤HSDs within the kidney indicates the importance of maintaining an optimal level of sex steroids and glucocorticoids which may be particularly critical during development.
Previously, we had determined that the Ke 6 gene is severely down-regulated in the kidneys of three different recessive murine models of polycystic kidney disease, the cpk, pcy, and jck mouse (1-4) . The cpk/cpk mouse was initially described and characterized as a model for the human recessive polycystic kidney disease because of the gross enlargement of the kidneys due to numerous cysts (43) . The disease closely resembled human autosomal recessive PKD in several aspects, recessive inheritance of the mutation, earliest cysts in the proximal tubules and later predominance of cysts in the collecting tubules, and aggressive nature of the disease with death occurring at infancy (43) . Recently, Woo and Greenbaum (44), re- ported that the ovary of the cpk/cpk mouse is markedly underdeveloped, determined by morphological, histological, and functional studies. The cpk/cpk females failed to superovulate in response to human chorionic gonadotropin treatment. Histological analyses revealed the presence of atresic follicles, and the sizes of the ovaries and uteri were much smaller than normal (44) . Recently the same laboratory also showed abnormal testicular development in the cpk homozygote males with fewer and immature seminiferous tubules. 2 It is possible that abnormal sex steroid metabolism is responsible for the underdevelopment of the gonads in the cpk/cpk mice. We expect to find a reduction in the expression of the Ke 6 gene in the gonads of the cpk homozygotes since we had previously found that Ke 6 mRNA levels is reduced in all tissues of this recessive murine PKD model (1) . Another recessive murine model of polycystic kidney disease, the kat (kidney, anemia, and testes) mouse has been described with testicular abnormalities (45) , which further indicates the tight linkage between kidney and gonadal differentiation.
The 17␤HSD ability of Ke 6 to promote either estradiol synthesis (reduction) or estradiol, testosterone, and dihydrotestosterone inactivation (oxidation) could be important in the development of both the kidney and the gonads of the cpk homozygotes by maintaining optimal levels of sex steroids within these organs. The development of the urinary and genital systems are closely associated in the earliest stages. The urogenital ridge gives rise to both the nephric and gonadal structures, and androgens and estrogens are likely to regulate differentiation and organization of both organ systems. Regulation of the intracellular levels of these steroids by Ke 6 and other 17␤HSDs would be expected to be important in the developing kidney and gonads. 
